Response to salvage chemotherapy following exposure to PD-1/PD-L1 inhibitors in patients with NSCLC

被引：0
|
作者：
Rothschild, S. I. [1 ]
Leger, P. [2 ]
Castellanos, E. L. [2 ]
Pillai, R. N. [3 ]
York, S. J. [2 ]
Horn, L. [2 ]
机构：
[1] Univ Spital Basel, Dept Internal Med, Med Oncol, Basel, Switzerland
[2] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
[3] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
91PD-PR
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
    Ming Yi
    Dechao Jiao
    Hanxiao Xu
    Qian Liu
    Weiheng Zhao
    Xinwei Han
    Kongming Wu
    Molecular Cancer, 17
  • [32] Whole body PD-1 and PD-L1 PET in pts with NSCLC
    Niemeijer, A-L.
    Smit, E.
    Bahce, I.
    Hoekstra, O.
    Huisman, M.
    van Dongen, G. A.
    Windhorst, B.
    Hendrikse, N.
    Poot, A. J.
    Vugts, D.
    Leung, D. K.
    Hayes, W.
    Smith, R. A.
    Wilson, L. M.
    Thunnissen, E.
    de langen, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] PD-1/PD-L1 inhibitors increase risk of hepatitis
    Reactions Weekly, 2020, 1809 (1) : 9 - 9
  • [34] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
    Yi, Ming
    Jiao, Dechao
    Xu, Hanxiao
    Liu, Qian
    Zhao, Weiheng
    Han, Xinwei
    Wu, Kongming
    MOLECULAR CANCER, 2018, 17
  • [35] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hayashi, Hidetoshi
    Nakagawa, Kazuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 818 - 830
  • [36] Progress on biphenyl derivatives as PD-1/PD-L1 inhibitors
    Wang, Shurong
    Wang, Yuli
    Yan, Hong
    MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (10) : 2089 - 2115
  • [37] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hidetoshi Hayashi
    Kazuhiko Nakagawa
    International Journal of Clinical Oncology, 2020, 25 : 818 - 830
  • [38] Efficiency of PD-1 and PD-L1 Inhibitors in Malignant Therapy
    Gappa, Birgit
    Kobold, Sebastian
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (01) : 7 - 8
  • [39] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [40] Trends in clinical development for PD-1/PD-L1 inhibitors
    Yu, Jia Xin
    Hodge, Jeffrey P.
    Oliva, Cristina
    Neftelinov, Svetoslav T.
    Hubbard-Lucey, Vanessa M.
    Tang, Jun
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (03) : 163 - 164
12345